American Vanguard Reports Full Year 2022 Results
American Vanguard Corporation (NYSE: AVD) reported a robust financial performance for the year ending December 31, 2022, with net sales reaching $610 million, a 9% increase from 2021. Net income rose by 47% to $27.4 million, while earnings per diluted share surged 51% to $0.92. The company also achieved an adjusted EBITDA of $73.1 million, a 15% growth year-over-year. The U.S. Crop business benefited from high commodity prices, leading to increased sales in various agricultural sectors. Looking ahead, AVD aims for 2023 net sales between $655M and $685M and continues to focus on strategic growth initiatives.
- Net sales increased by 9% to $610 million.
- Net income rose by 47% to $27.4 million.
- Earnings per diluted share increased by 51% to $0.92.
- Adjusted EBITDA grew by 15% to $73.1 million.
- International sales rose by 13%, achieving $100 million in Central America.
- Share buyback of 1.7 million shares, approximately 5.5% of outstanding shares.
- Non-Crop business experienced flat overall sales, with a 30% drop in the domestic consumer product market.
- Higher expected interest rates leading to increased expenses.
FY Net Income Increased
Fiscal 2022 Full Year Financial Highlights – versus Fiscal 2021 Full Year:
-
Net sales were
million in 2022, compared to$610 in 2021 (up$558 million 9% ) -
Net income was
in 2022, compared to$ 27.4 million in 2021 (up$18.6 million 47% ) -
Earnings per diluted share of
in 2022, compared to$0.92 in 2021 (up$0.61 51% ) -
Adjusted EBITDA1 of
in 2022, compared to$73.1 million in 2021 (up$63.5 million 15% )
2023 Performance Targets
Range |
Growth v. 2022 |
|
|
|
8 |
Gross Margin % |
38 |
Similar |
OPEX as % Sales |
31 |
Similar |
Adjusted EBITDA |
|
18 |
Net Income |
|
22 |
Conference Call
About
The Company, from time to time, may discuss forward-looking information. Except for the historical information contained in this release, all forward-looking statements are estimates by the Company’s management and are subject to various risks and uncertainties that may cause results to differ from management’s current expectations. Such factors include weather conditions, changes in regulatory policy and other risks as detailed from time-to-time in the Company’s
AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS
(In thousands, except share data) (Unaudited) |
||||||||
|
|
2022 |
|
|
2021 |
|
||
Assets |
|
|
|
|
|
|
||
Current assets: |
|
|
|
|
|
|
||
Cash and cash equivalents |
|
$ |
20,328 |
|
|
$ |
16,285 |
|
Receivables: |
|
|
|
|
|
|
||
Trade, net of allowance for doubtful accounts of |
|
|
156,492 |
|
|
|
149,326 |
|
Other |
|
|
9,816 |
|
|
|
9,595 |
|
Total receivables, net |
|
|
166,308 |
|
|
|
158,921 |
|
Inventories, net |
|
|
184,190 |
|
|
|
154,306 |
|
Prepaid expenses |
|
|
15,850 |
|
|
|
12,488 |
|
Income taxes receivable |
|
|
1,891 |
|
|
|
— |
|
Total current assets |
|
|
388,567 |
|
|
|
342,000 |
|
Property, plant and equipment, net |
|
|
70,912 |
|
|
|
66,111 |
|
Operating lease right-of-use assets |
|
|
24,250 |
|
|
|
25,386 |
|
Intangible assets, net of amortization |
|
|
184,664 |
|
|
|
197,841 |
|
|
|
|
47,010 |
|
|
|
46,260 |
|
Other assets |
|
|
10,769 |
|
|
|
16,292 |
|
Deferred income tax assets, net |
|
|
141 |
|
|
|
270 |
|
Total assets |
|
$ |
726,313 |
|
|
$ |
694,160 |
|
Liabilities and Stockholders’ Equity |
|
|
|
|
|
|
||
Current liabilities: |
|
|
|
|
|
|
||
Current installments of other liabilities |
|
$ |
— |
|
|
$ |
802 |
|
Accounts payable |
|
|
69,000 |
|
|
|
67,140 |
|
Customer prepayments |
|
|
110,597 |
|
|
|
63,064 |
|
Accrued program costs |
|
|
60,743 |
|
|
|
63,245 |
|
Accrued expenses and other payables |
|
|
20,982 |
|
|
|
20,745 |
|
Income taxes payable |
|
|
— |
|
|
|
3,006 |
|
Operating lease liabilities, current |
|
|
5,279 |
|
|
|
5,059 |
|
Total current liabilities |
|
|
266,601 |
|
|
|
223,061 |
|
Long-term debt, net of deferred loan fees |
|
|
51,477 |
|
|
|
52,240 |
|
Other liabilities, excluding current installments |
|
|
4,167 |
|
|
|
5,335 |
|
Operating lease liabilities, long-term |
|
|
19,492 |
|
|
|
20,780 |
|
Deferred income tax liabilities, net |
|
|
14,597 |
|
|
|
20,006 |
|
Total liabilities |
|
|
356,334 |
|
|
|
321,422 |
|
Commitments and contingent liabilities (Notes 5 and 11) |
|
|
|
|
|
|
||
Stockholders’ equity: |
|
|
|
|
|
|
||
Preferred stock, |
|
|
— |
|
|
|
— |
|
Common stock, |
|
|
3,444 |
|
|
|
3,426 |
|
Additional paid-in capital |
|
|
105,634 |
|
|
|
101,450 |
|
Accumulated other comprehensive loss |
|
|
(12,182 |
) |
|
|
(13,784 |
) |
Retained earnings |
|
|
328,745 |
|
|
|
304,385 |
|
|
|
|
425,641 |
|
|
|
395,477 |
|
Less treasury stock at cost, 5,029,892 shares in 2022 and 3,361,040 in 2021 |
|
|
(55,662 |
) |
|
|
(22,739 |
) |
Total stockholders’ equity |
|
|
369,979 |
|
|
|
372,738 |
|
Total liabilities and stockholders’ equity |
|
$ |
726,313 |
|
|
$ |
694,160 |
|
AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF OPERATIONS
Years ended (In thousands, except per share data) (Unaudited) |
||||||||||||
|
|
2022 |
|
|
2021 |
|
|
2020 |
|
|||
Net sales |
|
$ |
609,615 |
|
|
$ |
557,676 |
|
|
$ |
458,704 |
|
Cost of sales |
|
|
(368,263 |
) |
|
|
(343,629 |
) |
|
|
(286,114 |
) |
Gross profit |
|
|
241,352 |
|
|
|
214,047 |
|
|
|
172,590 |
|
Operating expenses |
|
|
(200,701 |
) |
|
|
(183,272 |
) |
|
|
(154,339 |
) |
Bargain purchase gain on business acquisition |
|
|
— |
|
|
|
171 |
|
|
|
4,657 |
|
Operating income |
|
|
40,651 |
|
|
|
30,946 |
|
|
|
22,908 |
|
Change in fair value of equity investments, net |
|
|
(732 |
) |
|
|
(790 |
) |
|
|
717 |
|
Other income |
|
|
— |
|
|
|
672 |
|
|
|
— |
|
Interest expense, net |
|
|
(3,954 |
) |
|
|
(3,687 |
) |
|
|
(5,178 |
) |
Income before provision for income taxes and loss on equity method investment |
|
|
35,965 |
|
|
|
27,141 |
|
|
|
18,447 |
|
Provision for income taxes |
|
|
(8,561 |
) |
|
|
(8,166 |
) |
|
|
(3,080 |
) |
Income before loss on equity method investment |
|
|
27,404 |
|
|
|
18,975 |
|
|
|
15,367 |
|
Loss from equity method investment |
|
|
— |
|
|
|
(388 |
) |
|
|
(125 |
) |
Net income |
|
$ |
27,404 |
|
|
$ |
18,587 |
|
|
$ |
15,242 |
|
Earnings per common share—basic |
|
$ |
0.94 |
|
|
$ |
0.62 |
|
|
$ |
0.52 |
|
Earnings per common share—assuming dilution |
|
$ |
0.92 |
|
|
$ |
0.61 |
|
|
$ |
0.51 |
|
Weighted average shares outstanding—basic |
|
|
29,234 |
|
|
|
29,811 |
|
|
|
29,450 |
|
Weighted average shares outstanding—assuming dilution |
|
|
29,872 |
|
|
|
30,410 |
|
|
|
29,993 |
|
AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES ANALYSIS OF SALES
For the years and quarters ended (Unaudited) |
||||||||||||||
|
For the quarters ended |
|
|
For the years ended |
|
|||||||||
|
2022 |
|
2021 |
|
|
2022 |
|
|
2021 |
|
||||
Net sales: |
|
|
|
|
|
|
|
|
|
|
||||
|
$ |
68,121 |
|
$ |
79,580 |
|
|
$ |
288,624 |
|
|
$ |
263,632 |
|
|
|
23,061 |
|
|
18,042 |
|
|
|
76,709 |
|
|
|
78,605 |
|
Total |
|
91,182 |
|
|
97,622 |
|
|
|
365,333 |
|
|
|
342,237 |
|
International |
|
68,797 |
|
|
61,991 |
|
|
|
244,282 |
|
|
|
215,439 |
|
Total net sales |
$ |
159,979 |
|
$ |
159,613 |
|
|
$ |
609,615 |
|
|
$ |
557,676 |
|
Gross profit: |
|
|
|
|
|
|
|
|
|
|
||||
|
$ |
27,910 |
|
$ |
31,255 |
|
|
$ |
132,509 |
|
|
$ |
109,568 |
|
|
|
10,431 |
|
|
9,396 |
|
|
|
35,257 |
|
|
|
37,443 |
|
Total |
|
38,341 |
|
|
40,651 |
|
|
|
167,766 |
|
|
|
147,011 |
|
International |
|
20,655 |
|
|
19,062 |
|
|
|
73,586 |
|
|
|
67,036 |
|
Total gross profit |
$ |
58,996 |
|
$ |
59,713 |
|
|
$ |
241,352 |
|
|
$ |
214,047 |
|
AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS
Years ended (In thousands) (Unaudited) |
||||||||||||
|
|
2022 |
|
|
2021 |
|
|
2020 |
|
|||
|
|
|
|
|
|
|
|
|
|
|||
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
|
|||
Net income |
|
$ |
27,404 |
|
|
$ |
18,587 |
|
|
$ |
15,242 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
|
|
|
|
|||
Depreciation and amortization of property, plant and equipment and intangible assets |
|
|
22,138 |
|
|
|
22,229 |
|
|
|
19,902 |
|
Loss on disposal of property, plant and equipment |
|
|
268 |
|
|
|
194 |
|
|
|
119 |
|
Amortization of other long-term assets |
|
|
3,573 |
|
|
|
3,943 |
|
|
|
3,947 |
|
Amortization and accretion of deferred loan fees and discounted liabilities |
|
|
289 |
|
|
|
359 |
|
|
|
309 |
|
Provision for bad debts |
|
|
1,171 |
|
|
|
649 |
|
|
|
1,002 |
|
Provision for inventory obsolescence |
|
|
340 |
|
|
|
1,034 |
|
|
|
738 |
|
Loan principal and interest forgiveness |
|
|
— |
|
|
|
(672 |
) |
|
|
— |
|
Fair value adjustment of contingent consideration |
|
|
610 |
|
|
|
758 |
|
|
|
250 |
|
Decrease in environmental liability |
|
|
— |
|
|
|
(167 |
) |
|
|
(1,155 |
) |
Stock-based compensation |
|
|
5,684 |
|
|
|
6,880 |
|
|
|
6,561 |
|
(Decrease) increase in deferred income taxes |
|
|
(5,278 |
) |
|
|
(2,090 |
) |
|
|
969 |
|
Changes in liabilities for uncertain tax positions or unrecognized tax benefits |
|
|
(1,441 |
) |
|
|
(1,783 |
) |
|
|
(2,092 |
) |
Change in equity investment fair value |
|
|
732 |
|
|
|
790 |
|
|
|
(717 |
) |
Loss from equity method investment |
|
|
— |
|
|
|
388 |
|
|
|
125 |
|
Bargain purchase gain |
|
|
— |
|
|
|
(171 |
) |
|
|
(4,657 |
) |
Net foreign currency adjustment |
|
|
(29 |
) |
|
|
(225 |
) |
|
|
126 |
|
Changes in assets and liabilities associated with operations, net of business combinations: |
|
|
|
|
|
|
|
|
|
|||
(Increase) decrease in net receivables |
|
|
(6,447 |
) |
|
|
(24,347 |
) |
|
|
15,407 |
|
(Increase) decrease in inventories |
|
|
(29,560 |
) |
|
|
8,323 |
|
|
|
6,683 |
|
(Increase) decrease in income tax receivable, net |
|
|
(4,910 |
) |
|
|
6,051 |
|
|
|
(287 |
) |
(Increase) decrease in prepaid expenses and other assets |
|
|
(3,082 |
) |
|
|
(4,581 |
) |
|
|
140 |
|
Increase in net operating lease liability |
|
|
68 |
|
|
|
286 |
|
|
|
18 |
|
Increase (decrease) in accounts payable |
|
|
1,704 |
|
|
|
8,783 |
|
|
|
(8,199 |
) |
Increase in deferred revenue |
|
|
47,551 |
|
|
|
19,280 |
|
|
|
36,803 |
|
(Decrease) increase in accrued program costs |
|
|
(2,449 |
) |
|
|
17,877 |
|
|
|
(2,517 |
) |
Increase in other payables and accrued expenses |
|
|
90 |
|
|
|
3,986 |
|
|
|
1,607 |
|
Payment of contingent consideration |
|
|
(1,321 |
) |
|
|
— |
|
|
|
— |
|
Net cash provided by operating activities |
|
|
57,105 |
|
|
|
86,361 |
|
|
|
90,324 |
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
|
|||
Capital expenditures |
|
|
(13,261 |
) |
|
|
(9,518 |
) |
|
|
(11,249 |
) |
Proceeds from disposal of property, plant and equipment |
|
|
84 |
|
|
|
— |
|
|
|
— |
|
Acquisitions of businesses and product lines |
|
|
— |
|
|
|
(10,000 |
) |
|
|
(19,342 |
) |
Intangible assets |
|
|
(1,293 |
) |
|
|
(524 |
) |
|
|
(4,014 |
) |
Investment |
|
|
— |
|
|
|
— |
|
|
|
(1,190 |
) |
Net cash used in investing activities |
|
|
(14,470 |
) |
|
|
(20,042 |
) |
|
|
(35,795 |
) |
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
|
|||
Payments under line of credit agreement |
|
|
(254,000 |
) |
|
|
(186,569 |
) |
|
|
(168,400 |
) |
Borrowings under line of credit agreement |
|
|
253,000 |
|
|
|
131,000 |
|
|
|
126,776 |
|
Payment of contingent consideration |
|
|
(68 |
) |
|
|
(1,301 |
) |
|
|
(1,227 |
) |
Net receipt from the issuance of common stock under ESPP |
|
|
837 |
|
|
|
743 |
|
|
|
721 |
|
Net receipt from the exercise of stock options |
|
|
827 |
|
|
|
172 |
|
|
|
1,603 |
|
Net payment from common stock purchased for tax withholding |
|
|
(2,067 |
) |
|
|
(2,955 |
) |
|
|
(2,745 |
) |
Repurchase of common stock |
|
|
(34,002 |
) |
|
|
(4,579 |
) |
|
|
— |
|
Payment of cash dividends |
|
|
(2,787 |
) |
|
|
(2,382 |
) |
|
|
(1,168 |
) |
Net cash used in financing activities |
|
|
(38,260 |
) |
|
|
(65,871 |
) |
|
|
(44,440 |
) |
Net increase in cash and cash equivalents |
|
|
4,375 |
|
|
|
448 |
|
|
|
10,089 |
|
Effect of exchange rate changes on cash and cash equivalents |
|
|
(332 |
) |
|
|
(86 |
) |
|
|
(747 |
) |
Cash and cash equivalents at beginning of year |
|
|
16,285 |
|
|
|
15,923 |
|
|
|
6,581 |
|
Cash and cash equivalents at end of year |
|
$ |
20,328 |
|
|
$ |
16,285 |
|
|
$ |
15,923 |
|
AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES RECONCILIATION OF NET INCOME TO EBITDA
For the years and quarters ended (Unaudited) |
|||||||
|
For the years ended |
|
|||||
|
2022 |
|
|
2021 |
|
||
Net income |
$ |
27,404 |
|
|
$ |
18,587 |
|
Provision for income taxes |
|
8,561 |
|
|
|
8,166 |
|
Interest expense, net |
|
3,954 |
|
|
|
3,687 |
|
Proxy costs |
|
1,785 |
|
|
|
— |
|
Depreciation and amortization |
|
25,711 |
|
|
|
26,172 |
|
Stock compensation expense |
|
5,684 |
|
|
|
6,880 |
|
Adjusted EBITDA1 |
$ |
73,099 |
|
|
$ |
63,492 |
|
|
For the quarters ended |
|
|||||
|
2022 |
|
|
2021 |
|
||
Net income |
$ |
3,898 |
|
|
$ |
4,874 |
|
Provision for income taxes |
|
(1,626 |
) |
|
|
2,842 |
|
Interest expense, net |
|
1,698 |
|
|
|
766 |
|
Depreciation and amortization |
|
6,406 |
|
|
|
6,146 |
|
Stock compensation expense |
|
1,288 |
|
|
|
1,571 |
|
Adjusted EBITDA1 |
$ |
11,664 |
|
|
$ |
16,199 |
|
_____________________________________
1 Adjusted EBITDA is not a financial measure calculated and presented in accordance with
View source version on businesswire.com: https://www.businesswire.com/news/home/20230313005774/en/
Company:
(949) 260-1200
williamk@amvac-chemical.com
Investor Representative
the
www.theequitygroup.com
Lcati@equityny.com
Source:
FAQ
What were American Vanguard's net sales for FY 2022?
How much did American Vanguard's net income increase in 2022?
What is the projected net sales range for American Vanguard in 2023?
What was the earnings per share for American Vanguard in 2022?